A Potential Antidote for Both Azide and Cyanide Poisonings

Area of Science:

• Toxicology
• Pharmacology
• Medicinal Chemistry

Background:

• Current therapeutics for azide poisoning are lacking.
• Existing cyanide antidotes are suboptimal and impractical for mass casualty incidents.
• Cobalt complexes are explored for their potential antidotal properties.

Purpose of the Study:

• To evaluate the efficacy of the cobalt (II/III) Schiff-base complex CoN4[14] as an antidote for azide and cyanide toxicity in mice.
• To compare the performance of CoN4[14] against the FDA-approved hydroxocobalamin for cyanide poisoning.
• To investigate the in vitro interaction mechanisms of CoN4[14] with cyanide and azide ions.

Main Methods:

• Animal models (mice) were challenged with lethal doses of sodium cyanide (NaCN) or sodium azide (NaN3).
• CoN4[14] was administered at varying doses and time points relative to toxicant exposure.
• Recovery rates and survival were assessed, alongside in vitro spectroscopic analysis of complex-ion interactions.

Main Results:

• CoN4[14] significantly improved survival and accelerated recovery in mice poisoned with NaCN, outperforming hydroxocobalamin.
• Administration of CoN4[14] prior to NaCN challenge resulted in 100% survival.
• CoN4[14] treatment led to a twofold increase in recovery speed for mice with NaN3 poisoning.

Conclusions:

• The Schiff-base complex CoN4[14] demonstrates significant potential as a dual antidote for both cyanide and azide poisoning.
• CoN4[14] offers superior therapeutic benefits compared to current FDA-approved cyanide antidotes.
• The observed efficacy is partly explained by CoN4[14]'s differential binding affinity for cyanide and azide ions.